Actively Recruiting
Individual and Structural-level Determinants Associated With Disparities Among Liver Transplant Patients
Led by Mayo Clinic · Updated on 2026-04-17
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand and address inequalities in liver transplant listing and transplantation among patients with end-stage liver dysfunction. The study focuses on how personal and system-level factors related to race, ethnicity, socioeconomic status, and gender affect liver transplant evaluation and listing. It also explores the use of stigmatizing language experienced by patients during this process. Participants with end-stage liver disease referred for transplant evaluation will complete questionnaires about their background, feelings, and behaviors. This observational study will establish a long-term group of these patients to examine disparities in transplant access and outcomes. Throughout the study, researchers will monitor participants for about one year to see who gets listed for a liver transplant and who actually receives one. They will also track survival rates and graft function up to one year after transplantation. Participants will be asked to fill out repeated questionnaires and provide information to help understand these disparities.
CONDITIONS
Brief Title
Disparities Among Liver Transplant Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with end-stage liver, kidney, or cardiac dysfunction
You will not qualify if you...
- Patients with more than one system with end stage organ dysfunction
- Patients with dementia, cognitive or sensory impairment
- Patients with prior solid organ transplant
- Patients with potential medical exclusions for transplant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 year
Participants with end-stage liver disease are observed over time to assess factors associated with liver transplant evaluation and listing, including questionnaires about background, emotions, and behaviors.
Periodic visits as needed for questionnaires and assessments
Trial Site Locations
Total: 1 location
1
Mayo Clinic Arizona
Phoenix, Arizona, United States, 85054
Actively Recruiting
Research Team
G
Gabrielle Montefiore
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here